Avisi Technologies

Avisi Technologies is an operator of a medical device company intended to treat glaucoma
2017
California, United States

Innovation

Industry Problem

Existing glaucoma implants often cause discomfort and scarring that limit their long-term success

R&D Focus

Nanotechnology-enabled ocular implant

Innovative Solution

Avisi Technologies nanotechnology-enabled ocular implant is a multichannel, ultrathin, and nonfibrotic drainage implant that creates a new outflow pathway for the aqueous humor in the eye

Solution Effectiveness

Avisi Technologies approach helps remove excess fluid inside the eye, relieving high pressures that damage the optic nerve and cause open-angle glaucoma

Investment Funding

Last Funding Stage

Seed

Total Funding Amount

$7.5M

Last Funding Amount

$4.06M

Last Funding Date

October 1, 2023

Startup Stage

Early-Stage

Lead Investors

Gaingels, America's Seed Fund, Accanto Partners

People

Founders

CEO

Products

Product

VisiPlate

Demo Product or Complete Product?

Complete Product

Awards and Recognitions

Media Apperance

Mystrategist, Technical.ly